Design of novel tripeptides with macrophage migration-enhancing activity

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 18, 1998, Pages 2517-2520

  Nunami, Ken Ichi ^a   Yamada, Masaki ^a   Shimizu, Ryo ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Antiinflammatories; Mimetics; Peptides and polypeptides; Solid phase synthesis

Indexed keywords

IMIDAZOLINE DERIVATIVE; TRIPEPTIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; LEUKOCYTE MIGRATION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; RABBIT; STRUCTURE ACTIVITY RELATION;

CELL MOVEMENT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DESIGN; MACROPHAGE ACTIVATION; OLIGOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032558514     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00410-7     Document Type: Article

References (5)

1. 1. For a recent review, see: Goodman M.; Ro S., Burger's Medicinal Chemistry and Drug Discovery, Fifth Edition, 1995, 1, 803 and references cited therein.
2. 2. Ueno M.; Sugita T.; Murakami T.; Takata I., Jpn. J. Pharmacol., 1997, 74, 221.
3. 3. Matsumoto K.; Suzuki M.; Yamamoto K.; Takata I.; Iwasawa Y.. US Patent, 1991, 5,051,441.
4. 4. King D. S.; Fields C. G.; Fields G. B., Int. J. Peptide Protein Res., 1990, 36, 255.
5. 5. Takata I.; Chida K.; Gordon M. R.; Myrvik Q. N.; Ricardo M. J.; Kucera L. S., J. Leukocyte Biol., 1987, 41, 248.